US Will Transition to Trivalent Flu Vaccines for 2024-2025

Published on March 8, 2024

On March 5, 2024, the FDA's Vaccines and Related Biological Products Advisory Committee (VRBPAC) met to discuss and make recommendations on the vaccine viruses for U.S. influenza vaccines for the 2024-2025 influenza season.

Continue reading on website
Other news

More than 100 Flu-Related Deaths in Children Reported So Far This Season

March 8, 2024
CDC reported 10 new flu-related pediatric deaths this week, bringing the total for the season to 103.

Optimizing boosters: How COVID mRNA vaccines reshape immune memory after each dose

March 8, 2024
COVID-19 vaccines elicit strong T-cell responses, but clonal-resolution analyses of these responses have not previously been performed. To address this gap, a team of researchers investigated the T- cell receptor sequence and tracked it using trammer analysis, uncovering key insights into the dynamics of T-cell responses. This study can lead to improved next-generation vaccines.